GLP-1 Weight-Loss Drugs: The Promise, the Pitfalls and What Comes Next | Chris Newbold

GLP-1 medications such as Ozempic, Wegovy and Mounjaro have rapidly changed the landscape of weight loss, diabetes and metabolic health. They can substantially reduce appetite and “food noise,” improve blood-glucose regulation and provide an important opportunity for people who have struggled repeatedly to lose weight.
However, rapid weight loss is not automatically the same as improved health.
In this episode of The Integrative Continuum, Dr. Richard Rocker is joined by Chris Newbold, Head of Nutrition at Cytoplan, to examine both the promise and the potential pitfalls of GLP-1 medications.
Chris explains how natural GLP-1 signalling works within the gut, brain and pancreas, and how GLP-1 receptor agonists alter appetite, gastric emptying, insulin signalling and reward pathways. The discussion also explores whether these medications can act as a bridge towards lasting dietary and lifestyle change rather than becoming the sole strategy:

Topics discussed include:
•How GLP-1 medications suppress appetite and food noise
•Their potential metabolic and cardiovascular benefits
•The difference between fat loss and loss of muscle, bone and water
•Why resistance training and adequate protein are essential
•Reduced food intake, digestion and nutrient absorption
•Constipation, diarrhoea, reflux and gallbladder concerns
•Possible changes in mood and motivation
•The risks of escalating the dose too quickly
•Weight regain after stopping treatment
•The importance of using the lowest effective dose
•How nutrition, supplementation and practitioner guidance may support safer outcomes
This is a balanced conversation about using a powerful medical tool with greater awareness, appropriate support and a clear long-term strategy.

Guest: Chris Newbold
Head of Nutrition at Cytoplan
To learn more about Chris Newbold and Cytoplan:
Website: www.cytoplan.co.uk
Email: nutrition@cytoplan.co.uk
Telephone: +44 (0)1684 310099

Host: Dr. Richard Rocker
The Integrative Continuum
Website: https://rockerclinic.com/
Instagram: https://www.instagram.com/drrichardrocker/
Facebook: https://www.facebook.com/RockerClinic
LinkedIn: https://www.linkedin.com/in/dr-richard-rocker-589127/

This podcast is for educational purposes only and is not a substitute for individual medical advice. Anyone using or considering a GLP-1 medication should discuss their circumstances, side effects and treatment plan with an appropriately qualified healthcare professional.